http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate
-
Novavax (NVAX), SK bioscience Announce Collaboration for Novavax' COVID-19 Vaccine Candidate
-
Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate
-
Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate
-
Novavax Reports Second Quarter 2020 Financial and Operational Results
-
Novavax Reports Second Quarter 2020 Financial and Operational Results
-
Novavax (NVAX) and Takeda (TAK) Announce Collaboration for Novavax' COVID-19 Vaccine Candidate in Japan
-
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
-
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
-
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
-
Novavax (NVAX), Serum Institute of India Announce Development and Commercial Collaboration
-
Novavax and Serum Institute of India Announce Development and Commercial Collaboration
-
Novavax and Serum Institute of India Announce Development and Commercial Collaboration
-
Novavax to Host Conference Call to Discuss Second Quarter Financial and Operating Results on August 10, 2020
-
Novavax to Host Conference Call to Discuss Second Quarter Financial and Operating Results on August 10, 2020
-
Novavax (NVAX) Reports Positive Phase 1 Data for COVID-19 Vaccine Candidate
-
Novavax (NVAX) says phase 1 data for COVID-19 vaccine candidate show it was generally well-tolerated and elicited robust antibody responses
-
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
-
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
-
Novavax (NVAX), FUJIFILM Diosynth Biotechnologies Enter Large Scale Manufacturing Deal of COVID-19 Vaccine Candidate
-
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
-
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
-
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
-
Novavax (NVAX) to Present COVID-19 Vaccine Candidate Progress at 2nd ISV COVID-19 Vaccines Virtual Congress
-
Novavax to Present COVID-19 Vaccine Candidate Progress at 2nd ISV COVID-19 Vaccines Virtual Congress
-
Novavax to Present COVID-19 Vaccine Candidate Progress at 2nd ISV COVID-19 Vaccines Virtual Congress
-
Novavax (NVAX) Announces $1.6 Billion Funding from Operation Warp Speed for its COVID-19 Vaccine
-
Novavax Announces $1.6 Billion Funding from Operation Warp Speed
-
Novavax Announces $1.6 Billion Funding from Operation Warp Speed
-
Novavax Announces Updates to Leadership Team
-
Novavax Announces Updates to Leadership Team
-
Novavax Expands Executive Leadership and Announces Key Promotions
-
Novavax Expands Executive Leadership and Announces Key Promotions
-
Novavax to Participate in H.C. Wainwright Fireside Chat Series
-
Novavax to Participate in H.C. Wainwright Fireside Chat Series
-
Novavax (NVAX) Names Filip Dubovsky as CMO
-
Novavax Announces Additions to Executive Leadership
-
Novavax Announces Additions to Executive Leadership
-
Novavax (NVAX) Announces David Mott to Board
-
Novavax Appoints Biotechnology Veteran David Mott to Board of Directors
-
Novavax Appoints Biotechnology Veteran David Mott to Board of Directors
-
Novavax (NVAX) Raises $200M from Private Placement with RA Capital
-
Novavax to Raise $200 Million from Private Placement with RA Capital
-
Novavax to Raise $200 Million from Private Placement with RA Capital
-
Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital
-
Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital
-
Novavax (NVAX) Awarded DoD Contract for COVID-19 Vaccine
-
Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
-
Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
-
Novavax (NVAX) Expands Large-Scale Global Manufacturing Capacity, Acquires Praha Vaccines in Czech Republic for $167 million

